Treatments for fatigue in multiple sclerosis: A rapid and systematic review

Treatments for fatigue in multiple sclerosis: A rapid and systematic review

Show other versions (1)

Bibliographic Details
Main Authors:	Branas, P, Jordan, R, Fry-Smith, A, Burls, A, Hyde, C
Format:	Journal article
Language:	English
Published:	2000

Similar Items

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
by: Brañas, et al.
Published: (2000-01-01)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
by: Brañas, P, et al.
Published: (2000)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
by: Stewart, A, et al.
Published: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: A rapid and systematic review
by: Stewart, A, et al.
Published: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review
by: A. Stewart, et al.
Published: (2001-01-01)

Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: A rapid and systematic review
by: Jobanputra, P, et al.
Published: (2001)

Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review.
by: Jobanputra, P, et al.
Published: (2001)

Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review
by: P. Jobanputra, et al.
Published: (2001-01-01)

Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
by: Meads, C, et al.
Published: (2000)

Coronary artery stents in the treatment of ischaemic heart disease: A rapid and systematic review
by: Meads, C, et al.
Published: (2000)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept
by: C. Cummins, et al.
Published: (2002-01-01)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation
by: A. Burls, et al.
Published: (2002-01-01)

Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses
by: Crawford A, et al.
Published: (2014-08-01)

The effect of fatigue on postural control in individuals with multiple sclerosis: a systematic review
by: Parisa Sedaghati, et al.
Published: (2023-11-01)

Patient education for people with multiple sclerosis-associated fatigue: A systematic review.
by: Maria Janina Wendebourg, et al.
Published: (2017-01-01)

Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review
by: Abril Oliva Ramirez, et al.
Published: (2021-12-01)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: W. Clark, et al.
Published: (2003-01-01)

A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis
by: Gavin Giovannoni, et al.
Published: (2020-09-01)

Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
by: Clegg, et al.
Published: (2000-01-01)

Fatigue in Multiple Sclerosis: (An update)
by: Hossein Zarei
Published: (2007-10-01)

The use of modafinil for the treatment of fatigue in multiple sclerosis: A systematic review and meta‐analysis of controlled clinical trials
by: Shamas Ghazanfar, et al.
Published: (2024-07-01)

Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis
by: Xiaodong Yi, et al.
Published: (2024-10-01)

Brain Structural and Functional Alterations in Multiple Sclerosis-Related Fatigue: A Systematic Review
by: Chiara Barbi, et al.
Published: (2022-06-01)

Treatments for spasticity and pain in multiple sclerosis: a systematic review
by: S Beard, et al.
Published: (2003-12-01)

Riluzole for motor neurone disease [3] (multiple letters)
by: Sandercock, J, et al.
Published: (2001)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
by: D. L. Klabukova, et al.
Published: (2018-07-01)

The Efficacy of Psychological Interventions for Managing Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis
by: Aung Zaw Zaw Phyo, et al.
Published: (2018-04-01)

Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence.
by: Jordan, R, et al.
Published: (2006)

The Seasonal Fluctuation of Fatigue in Multiple Sclerosis
by: Matthias Grothe, et al.
Published: (2022-06-01)

Impairment, disability and fatigue in multiple sclerosis
by: Shahnaz Shahrbanian, et al.
Published: (2018-05-01)

Fatigue in multiple sclerosis and its relation with depression
by: M. Ben Abdallah, et al.
Published: (2022-06-01)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Chen, Y, et al.
Published: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
by: Chen, Y, et al.
Published: (2006)

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
by: Richards, R, et al.
Published: (2000)